Pharmacokinetics and safety of SHR0302, a selective JAK1 inhibitor, in Chinese patients with hepatic impairment.

AiSuDa (ivarmacitinib) - Jiangsu Hengrui Pharma, Arcutis

http://www.ncbi.nlm.nih.gov/pubmed/42466005

Chong Chen; Di Wang; Hong Zhang; Hongda Lin; Jiajia Mai; Min Wu; Qinglong Jin

Jul 18, 2026